Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

2(3→20)-abeo-taxoids with adipogenesis inhibitory activity from the leaves and twigs of Taxus chinensis var. mairei.

Long LP., Fan XY., Yu YH., Xu YL., Mao LX., Tang X.

Animal Study on Hip, published in Phytochemistry (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Phytochemistry (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42119959
DOI
10.1016/j.phytochem.2026.114958

Abstract (original English)

Phytochemical investigation of the leaves and twigs of Taxus chinensis var. mairei yielded seven previously undescribed taxane diterpenoids (1-7). Their structures were elucidated through comprehensive spectroscopic analysis, electronic circular dichroism calculations, and single-crystal X-ray diffraction. Compounds 1-4 were characterized as 2(3→20)-abeo-taxoids with extended conjugation, while 7 was distinguished by a rare α-substituted cinnamoyloxy moiety. All compounds were evaluated for their inhibitory effects on adipogenesis in 3T3-L1 adipocytes. Among them, compounds 4 and 5 exhibited significant triglyceride-lowering activity, with IC 50 values of 4.42 ± 0.19 μM and 5.44 ± 0.58 μM, respectively, demonstrating superior potency compared to the positive agent fenofibrate.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Plant LeavesAnimalsAdipogenesisTaxus3T3-L1 CellsMiceTaxoidsMolecular StructurePlant StemsStructure-Activity Relationship

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research